MRMD (MariMed) EBIT per Share : $-0.01 (TTM As of Sep. 2024)

View and export this data going back to 2012. Start your Free Trial

What is MariMed EBIT per Share?

MariMed's EBIT per Share for the three months ended in Sep. 2024 was $0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.01.

During the past 12 months, the average EBIT per Share Growth Rate of MariMed was -62.30% per year. During the past 3 years, the average EBIT per Share Growth Rate was -4.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for MariMed's EBIT per Share or its related term are showing as below:

MRMD' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -10.8 Med: 31 Max: 263.4
Current: -4.4

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of MariMed was 263.40% per year. The lowest was -10.80% per year. And the median was 31.00% per year.

MRMD's 3-Year EBIT Growth Rate is ranked worse than
69.62% of 836 companies
in the Drug Manufacturers industry
Industry Median: 6.8 vs MRMD: -4.40

MariMed's EBIT for the three months ended in Sep. 2024 was $1.4 Mil.

MariMed EBIT per Share Historical Data

The historical data trend for MariMed's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MariMed EBIT per Share Chart

MariMed Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.33

0.04

0.07

0.06

0.01

MariMed Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															0.01	-0.02	0.01	-	-

MariMed EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

MariMed's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	2.589	/	363.403
=	0.01

MariMed's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1.365	/	380.599
=	0.00

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

MariMed (OTCPK:MRMD) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

MariMed EBIT per Share Related Terms

Thank you for viewing the detailed overview of MariMed's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

MariMed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MariMed Inc (OTCPK:MRMD) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

MRMD:Canada

Address

10 Oceana Way, Floor 2, Norwood, MA, USA, 02062

Website

https://www.marimedinc.com

MariMed Inc is a multi-state operator in the United States cannabis industry. It develops, operates, manages, and optimizes regulatory-compliant facilities for the cultivation, production, and dispensing of medical and adult-use cannabis. MariMed also licenses its proprietary brands of cannabis products along with other top brands in domestic markets Sources of revenue are comprised of Product sales (retail and wholesale), Real estate rental income, Supply procurement, Management fees and Licensing fees.

Executives

Jon R Levine	10 percent owner	C/O MARIMED INC., 10 OCEANA WAY, NORWOOD MA 02062
Timothy Shaw	officer: Chief Operating Officer	C/O MARIMED INC, 10 OCEANA WAY, NORWOOD MA 02062
Kathleen Tucker	director	C/O 10 OCEANA WAY, 2ND FLOOR, NORWOOD MA 02062
Susan M. Villare	officer: Chief Financial Officer	C/O MARIMED INC., 10 OCEANA WAY, NORWOOD MA 02062
Selhub Eva M.d.	director	C/O MARIMED INC., 10 OCEANA WAY, NORWOOD MA 02062
David R Allen	director	C/O CONVERTED ORGANICS INC., 7A COMMERCIAL WHARF WEST, BOSTON MA 02110
Thomas Kidrin	director	11 ROYAL ROAD, BROOKLINE MA 02445
Edward J Gildea	director	C/O CONVERTED ORGANICS INC., 7A COMMERCIAL WHARF WEST, BOSTON MA 02110
Jay Coleman	director	310 EAST 46TH ST. APT 9 F, NEW YORK NY 10017
Robert N Fireman	director	145 ROSEMARY ST. SUITE H-2, NEEDHAM MA 02494
Worlds.com, Inc.	director, 10 percent owner, officer: PRESIDENT, CEO, other: TREASURER, SECRETARY	11 ROYAL ROAD, BROOKLINE MA 02445
Christopher John Ryan	officer: CFO, VICE PRESIDENT	11 ROYAL RD, BROOKLINE MA 02445